Pharmena S.A. reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was PLN 0.171 million compared to PLN 0.156 million a year ago. Net income was PLN 29.41 million compared to net loss of PLN 0.743 million a year ago.

Basic earnings per share from continuing operations was PLN 2.47 compared to basic loss per share from continuing operations of PLN 0.3 a year ago. Diluted earnings per share from continuing operations was PLN 2.47 compared to diluted loss per share from continuing operations of PLN 0.3 a year ago. Basic earnings per share was PLN 2.64 compared to basic loss per share of PLN 0.07 a year ago.

Diluted earnings per share was PLN 2.64 compared to diluted loss per share of PLN 0.07 a year ago.